Flutamide

CAS No. 13311-84-7

Flutamide( Niftolide | NSC 147834 | NSC 251876 | SCH 13521 )

Catalog No. M11320 CAS No. 13311-84-7

Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG 27 In Stock
500MG 41 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    Flutamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.
  • Description
    Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Niftolide | NSC 147834 | NSC 251876 | SCH 13521
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    13311-84-7
  • Formula Weight
    276.21
  • Molecular Formula
    C11H11F3N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 55 mg/mL (199.12 mM); DMSO: 55 mg/mL (199.12 mM)
  • SMILES
    CC(C)C(NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1)=O
  • Chemical Name
    N-(4-nitro-3-(trifluoromethyl)phenyl)isobutyramide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chang HC, et al. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11173-7.
molnova catalog
related products
  • AZD3514

    AZD3514 is a potent and oral androgen receptor downregulator with Ki of 2.2 μM and has ability of reducing AR protein expression.Phase 1.

  • Ralaniten triacetate

    Ralaniten triacetate (EPI-506), a precursor of Ralaniten, is a first-of-its-kind, orally active androgen receptor N-terminal structural domain (AR-NTD) inhibitor with anticancer activity and can be used to study prostate and breast cancer.

  • MK-0773

    A potent, selective androgen receptor modulator (SARM) with binding IC50 of 6.6 nM.